Head Of Dmpk

Recursion Pharmaceuticals

New York, New York, United States
Base: $284,900 to $400,950; bonus/equity: annual b...
On-site
Phd in pharmacokinetics or related field
15+ years pharmaceutical industry experience
Expertise in small molecule dmpk
This role involves leading the DMPK strategy to transition programs from early hit-identification through to IND-enabling studies and early clinical development

Job Summary

  • This role involves leading the DMPK strategy to transition programs from early hit-identification through to IND-enabling studies and early clinical development.
  • The successful candidate will partner with Data Science and ML teams to refine predictive ADME models and de-risk the portfolio.
  • Recursion offers a competitive base salary ranging from $284,900 to $400,950 along with annual bonus and equity compensation.

Matching Summary

This role involves leading the DMPK strategy to transition programs from early hit-identification through to IND-enabling studies and early clinical development.

Salary

Base: $284,900 to $400,950; Bonus/Equity: Annual bonus and equity compensation eligible; Benefits: Comprehensive benefits package included

Skills & Requirements

Must-have

  • PhD in Pharmacokinetics or related field
  • 15+ years pharmaceutical industry experience
  • Expertise in small molecule DMPK
  • IND submission requirements knowledge
  • In vitro and in vivo ADME expertise

Nice-to-have

  • Experience with ADCs and peptides
  • CNS exposure property knowledge
  • Comfortable with computational approaches
  • Strong cross-functional collaboration skills
  • Talent development and team leadership

Key Requirements

  • PhD required in Pharmacokinetics, Drug Metabolism, or Pharmacology
  • 15+ years of industry experience moving programs to development
  • Deep expertise in small molecule DMPK
  • Familiarity with IND submission requirements
  • Proven track record managing CROs

Work Rights

Not specified

Tailored Resume

Cover Letter